Anavex Life Sciences Corp (AVXL)

[Investor2014]

If the fda dictated that 450 were needed in the trial for it to review the results, why does the TGA and Australian authorities need that number since it is a much smaller population there.

The population size of a country has nothing to do with how large a clinical trial population needs to be for statistical power.